Related Experiment Video
Updated: Apr 15, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Genomic Analysis of Puerto Rican Hispanic/Latino Men with Prostate Cancer
Jamie K Teer1, Gilberto Ruiz Deya2, Sol V Pérez-Mártir3
1Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Genomic analysis of prostate cancer in Puerto Rican Hispanic/Latino men reveals distinct mutation profiles and gene expression patterns. These findings highlight the need for inclusive studies to improve personalized cancer care for underrepresented populations.
Area of Science:
- Genomics
- Oncology
- Population Health
Background:
- Puerto Rican Hispanic/Latino (PR H/L) men face higher prostate cancer incidence and mortality.
- Socio-economic and biological factors contribute to this disparity.
- The Puerto Rico BioBank is the first cancer tissue biobank at a Hispanic-Serving Institution.
Purpose of the Study:
- To characterize the genomic features of prostate cancer in 35 PR H/L men.
- To identify potential genomic markers associated with disease aggressiveness and progression.
- To inform future personalized treatment strategies for this population.
Main Methods:
- Whole-exome sequencing of tumor samples.
- RNA sequencing of tumor samples.
- Analysis of mutation profiles and gene expression patterns.
Main Results:
- Distinct mutation profiles and gene expression patterns were observed in PR H/L men.
- Mutations in TP53 and TMPRSS2-ERG gene fusions were less common compared to broader populations.
- Observed genomic differences may correlate with disease aggressiveness and progression.
Conclusions:
- This pilot study advances understanding of ethnicity-specific genetic factors in prostate cancer.
- Inclusive genomic studies are crucial for underrepresented patient cohorts.
- Further research with larger cohorts is needed to fully characterize PR H/L prostate cancer genomics and enable personalized medicine.
Related Concept Videos
Cancer Survival Analysis
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets

